CoChat

l -5-Hydroxytryptophan treatment of sleep terrors in children

Bruni, Oliviero, Ferri, Raffaele, Miano, Silvia, Verrillo, Elisabetta · 2004 · European Journal of Pediatrics

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Abstract

Unlabelled To test the hypothesis that the administration of L -5-hydroxytryptophan (L -5-HTP) might exert beneficial effects on sleep terrors, we carried out an open pharmacological trial in a group of children with sleep terrors compared to a group of children with the same disorder but without L -5-HTP treatment. Participants in the trial were 45 children (34 males and 11 females; age range 3.2-10.6 years), referred to the Sleep Centre of the Department of Developmental Neurology and Psychiatry of the University of Rome "La Sapienza", affected by sleep terrors. All subjects underwent: (1) complete medical and sleep history; (2) complete neurological examination and EEG recording whilst awake and sleeping, (3) a structured sleep diary for 2 months, (4) after 1 month, all subjects were examined again from the clinical and EEG points of view and (5) after 6 months, a structured interview in order to evaluate the clinical outcome. After the first visit, L -5-HTP was administered (2 mg/kg per day) at bedtime to 31 randomly selected patients for a single period of 20 consecutive days. After 1 month of treatment, 29/31 (93.5%) of patients showed a positive response. In the comparison group without drug therapy, after 1 month, the episodes disappeared only in four children (28.6%) while ten children (71.4%) showed the persistence of episodes with the same frequency as before. After 6 months, 26/31 (83.9%) of children treated with L -5HTP were sleep terror-free, while in five children (16.1%) sleep terror episodes persisted. Of the children in the comparison group, ten (71.4%) continued to show sleep terrors at 6-month follow-up.Conclusion to our knowledge, this is the first study demonstrating the efficacy of a new drug treatment for sleep terrors. These results confirm our initial hypothesis and represent evidence that treatment with L -5-hydroxytryptophan is able to modulate the arousal level in children and to induce a long-term improvement of sleep terrors.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00431-004-1444-7

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 36 references

Cited by

See all 115

Metadata

Authors
Bruni, O., Ferri, R., Miano, S., & Verrillo, E.
Affiliations
  • Sapienza University of Rome (IT)
  • Oasi Maria SS (IT)
Corresponding author
Bruni, Oliviero
Venue
European Journal of Pediatrics
Published
2004-05-14
Volume
163
Issue
7
Pages
402-7
ISSN
  • 0340-6199 (ISSN-L)
  • 1432-1076
OpenAlex
W1996708083
Cited by
108
References
35
Citations by year
2026: 5 · 2025: 5 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 11 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 8 · 2015: 1 · 2014: 4 · 2013: 6 · 2012: 2
FWCI
2.35
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • European Journal of Pediatrics (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
  • Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Keywords
sleep terrors, L-5-hydroxytryptophan, children, pharmacotherapy, serotonin precursor, sleep disorders, arousal level, treatment efficacy
MeSH terms
Child, Child, Preschool, Female, Follow-Up Studies, Humans, 5-Hydroxytryptophan, Male, Treatment Outcome, Night Terrors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: l -5-Hydroxytryptophan treatment of sleep terrors in children. https://app.cochat.ai/papers/10.1007/s00431-004-1444-7
The paper
Bruni, O., Ferri, R., Miano, S., & Verrillo, E. (2004). l -5-Hydroxytryptophan treatment of sleep terrors in children. European Journal of Pediatrics. https://doi.org/10.1007/s00431-004-1444-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.